Countries
Peptides around the world: where they are prescribed, compounded, gray, or banned.
Posture summaries for the headline countries are below; the full 28-country census (USA, China, Mexico, Canada, UK, Germany, France, Spain, Netherlands, Switzerland, UAE, Thailand, Costa Rica, Panama, Colombia, Brazil, Australia, Japan, South Korea, India, Turkey, Czechia, Croatia, Poland, Russia, South Africa, New Zealand, Ireland/Sweden) lives in our research library and expands into pages as the build proceeds. Two patterns repeat everywhere: no regulator in the set has approved BPC-157 or TB-500 as a medicine, and every gray market is a supply chain that starts in the same few places — which is why China gets a chapter, not a row.
Australia
Among the strictest in our set: prescription-only, the TGA is aggressive on imports, and compounding has faced crackdowns. High enforcement interest,
Go →China — The Supply-Chain Chapter
The world's bulk peptide/API manufacturing hub; export-driven, and domestic rules are not the export reality. CBP seized roughly 130,000 vials nationa
Go →Mexico
A clinic hub where regenerative practices bundle peptides into stem-cell and recovery programs (the Eterna model; Tijuana price figures circulating on
Go →UAE (Dubai)
A high-end clinic hub (Eterna's Dubai arm) inside a controlled-medicines regime: the lawful channel is the clinic, and the clinic channel is real busi
Go →United Kingdom
Injectable peptides are prescription-only medicines; a research-chemical gray market operates anyway, and the UK is home to The Peptide Watch, a volun
Go →United States
Prescription + the 503A/503B compounding framework; contested peptides sat in legal limbo until the October 30, 2026 enforcement-discretion policy — d
Go →